Jens Nordvig: Tweet Thread 2 on Evergrande. 19 Sept 2021

Jens Nordvig: Tweet Thread 2 on Evergrande. 19 Sept 2021

Follow us on Twitter: Exante Data and Jens

Yesterday (Sept 18th), I did a mini-thread on what is going on under the surface in Chinese High Yield credit (and it generated A LOT of feedback). Hence, here is a follow up thread on the structural issues in Chinese real estate, and differences to the US in 2008.

Today, I will show some background data on the structural problem in Chinese real estate, and offer some basic perspectives on how the situation differs from the US in 2008 (not better or worse, but simple different)

The memory from the US in 2007-2008 is still fresh. The US housing market was too hot. There was too much leverage / building. And we ended up with a big crisis => the losses had to be allocated (globally), and policy makers were not willing to (or politically able) fill the gaps.

What is the Chinese situation? In China’s case, there is also an overbuilding problem. Very broadly, the capital stock per capita is, for example, is high given the country’s income level.

 

But let us focus on real estate more specifically. Here is a chart from an academic paper comparing floor area per capita in various countries (only up to 2012) China has been catching up with very wealthy countries fast.

The trend has continued (and even accelerated) in recent years, and the floor area per capita is now likely around 50 m^2 (if we extrapolate the trend after 2018) and that would put China above almost all European countries (well above Germany and the UK; look at the chart above).

And then there are vacancy rates. This can be measured in many different ways (here via satellite), and a lot of Chinese cities really stand out. Way above the US and Japan, for example.

Here is another metric that tells you something about how inventory has accumulated in China in recent years (and also something about how policy has tried to address it more recently, generating a peak last year).

And then there are prices. Let us start with levels relative to incomes. The high end Chinese cities look VERY EXTREME in a global comparison. London used to be regarded as expensive, but look at Shanghai, Beijing and Shenzhen (London is cheap!)

 

This brings us to prices (in change space). So far, we have not seen any dramatic price declines in China. In yoy terms (and even mom terms) we still have price increases. In this sense, a big correction (even if Evergrande is already correcting) is still ahead…

And now a few observations on why the US situation in 2008 is different from China in 2021, even if both countries are facing a challenge around overbuilding and likely price corrections…

First, monetary policy in China is different. Whereas many so-called developed countries around the world have embraced zero rates and QE policy over the last 10 years, China is not doing the same.

 
Here is a picture of the Chinese yield curve, short swap rates (which are close to policy rates) are around 2.5% and longer rates around 3.0% (more for end-users that do not have access to institutional money markets) In other words, China does not want to maximize credit growth.
 

 

Second, the problem around developers (Evergrande foremost) was not the same in the US in 2007-2008. Yes, builders in the US took a hit. But the leverage was not on their own balance sheet => they all survived Here is a stock price chart: Horton, Lennar, Pulte (all still around).

Third, the Chinese banking system is state-owned, and everybody around the world knows about Lehman. Policy makers may want to see deleveraging in the real estate sector. But Chinese policy makers do not want to see a broad tightening of credit conditions.

Fourth, foreign involvement is small in China. It is true that the high yield bond market has a sizable USD component (mostly foreign). But relative to the US, where subprime exposure was sold around the world, it is a much more local (controllable) system.

Fifth, there is the broader mortgage market. LTVs are different, & mortgage law is different too (full recourse in China, vs hand in keys approach in the US). Hence, the mortgage default cycle (at retail level) will not mirror the US one.

That said, prices could tank, so LTVs ex ante may not reflect future LTVs well. This is the reason that prices are so crucial to monitor. And prices have not moved much yet In the US price growth peaked in 2005 and turned negative in 2007. In China, the turning point is ahead.

So what is the bottom line: Yesterday, I commented on the observable stress in the Chinese high-yield credit market. It is severe in real-estate. But other sectors are (for now) holding up. Today, I have shown a bunch of data, highlighting that the structural issues are BIG. The risk for China is that house prices, and real estate prices more broadly will drop very significantly, with negative implications for consumer confidence and growth. This is a risk that is still ahead…In terms of financial contagion, the risks are very different from the US in 2008, as policy makers around the world have all learnt to avoid ‘Lehman moments’. It is highly likely that China will push the state banks to continue to lend to ‘other’ sectors. As such, a broad-based credit crunch does not seem likely (credit supply will be ok). But if the housing market tanks, sentiment will follow, and credit demand could be a major problem. China is different. They have a major challenge at hand, and they will handle it differently. They want to deleverage real estate, without causing ransom casualties in other sectors => big decisions ahead…It is likely to be a situation with more ‘real contagion’ (through sectoral activity adjustment, domestically and internationally), as opposed to uncontrolled financial stress and random macro-level credit tightening.

I will leave it at that. We have to watch how contagion effects evolve (so far, real estate centric). But the structural issues at hand are VERY big, so it is certainly not a time to relax. More threads ahead, I guess.

 

END

Exante Data © 2021. All rights reserved. Personal Data Usage Policy


This site is provided for informational purposes only.  The information included in this site should not be used as the sole basis for making a decision as to whether or not to invest in any particular security. In making an investment decision, you must rely on your own examination of the securities and the terms of the offering. You should not construe the contents of these materials as legal, tax, investment or other advice, or a recommendation to purchase or sell any particular security.

The information included in this site is based upon information reasonably available to Exante as of the date noted herein. Furthermore, the information included in this site has been obtained from sources that Exante believes to be reliable; however, these sources cannot be guaranteed as to their accuracy or completeness. Information contained in this site does not purport to be complete, nor does Exante undertake any duty to update the information set forth herein. No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information contained herein, by Exante, its members, partners or employees, and no liability is accepted by such persons for the accuracy or completeness of any such information.

This site contains certain “forward-looking statements,” which may be identified by the use of such words as “believe,” “expect,” “anticipate,” “should,” “planned,” “estimated,” “potential,” “outlook,” “forecast,” “plan” and other similar terms. Examples of forward-looking statements include, but are not limited to, estimates with respect to financial condition, results of operations, and success or lack of success of certain investment strategy. All are subject to various factors, including, but not limited to, general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting the operations of the companies identified herein, any or all of which could cause actual results to differ materially from projected results.

X
Get more information about Exante Data
X
Get Ahead With Our Updates with Our Exante Newsletter